Conspectus Colorectal cancer (CRC) is one of the most prevalent cancers worldwide.
Delineating biological markers (biomarkers) for early detection, when treatment is most …

Aberrant glycosylation is considered to be a hallmark of colorectal cancer (CRC), as
demonstrated by various studies. While the N-glycosylation of cell lines and serum has been …

Glycomics may assist in uncovering the structure–function relationships of protein
glycosylation and identify glycoprotein markers in colorectal cancer (CRC) research. Herein …

Alterations in glycosylation are seen in many types of cancer, including colorectal cancer
(CRC). Glycans, the sugar moieties of glycoconjugates, are involved in many important …

All human cells are covered by glycans, the carbohydrate units of glycoproteins, glycolipids,
and proteoglycans. Most glycans are localized to cell surfaces and participate in events …

Colorectal cancer is the third most common cancer worldwide with an annual incidence of∼
1 million cases and an annual mortality rate of∼ 655,000 individuals. There is an urgent …

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. An increased
molecular understanding of the CRC pathology is warranted to gain insights into the …

Simple Summary Incidence of colorectal cancer (CRC) has been rising in Brazil. To date, no
reliable biomarker has been described in CRC for diagnosis and prognosis. Modifications in …

Simple Summary The detection of colorectal cancer (CRC) at an early stage is increasing
due to the implementation of screening programs. Local excision of early CRC is potentially …

Aberrant protein glycosylation is a prominent cancer feature. While many tumour-associated
glycoepitopes have been reported, advances in glycoanalytics continue to uncover new …